The global Xanthinol Nicotinate Tablets market size is predicted to grow from US$ 35.6 million in 2025 to US$ 45.8 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031.

Nicotinic acid xanthinol tablets are a compound drug containing two active ingredients,   niacin and xanthinol, which are mainly used to improve microcirculation,   dilate blood vessels and lower blood lipids. It is widely used in the   treatment of chronic cerebrovascular diseases, peripheral vascular diseases,   varicose veins and their complications by promoting blood circulation,   increasing tissue oxygen supply, and regulating lipid metabolism. In   addition, the drug also has a certain anti-platelet aggregation effect, helps   prevent thrombosis, and is suitable for the adjuvant treatment of   cardiovascular diseases.

United States market for Xanthinol Nicotinate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Xanthinol Nicotinate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Xanthinol Nicotinate Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Xanthinol Nicotinate Tablets players cover Inner Mongolia Haitian Pharmaceutical Co., Ltd., Guangzhou Kanghe Pharmaceutical Co., Ltd., Guangxi Baoruitan Pharmaceutical Co., Ltd., Shenyang Guancheng Pharmaceutical Co., Ltd., Shandong Yikang Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Xanthinol Nicotinate Tablets Industry Forecast” looks at past sales and reviews total world Xanthinol Nicotinate Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Xanthinol Nicotinate Tablets sales for 2025 through 2031. With Xanthinol Nicotinate Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Xanthinol Nicotinate Tablets industry.

This Insight Report provides a comprehensive analysis of the global Xanthinol Nicotinate Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Xanthinol Nicotinate Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Xanthinol Nicotinate Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Xanthinol Nicotinate Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Xanthinol Nicotinate Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Xanthinol Nicotinate Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    100mg
    150mg

Segmentation by Application:

    Hospital
    Clinic
    Other

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Inner Mongolia Haitian Pharmaceutical Co., Ltd.
    Guangzhou Kanghe Pharmaceutical Co., Ltd.
    Guangxi Baoruitan Pharmaceutical Co., Ltd.
    Shenyang Guancheng Pharmaceutical Co., Ltd.
    Shandong Yikang Pharmaceutical Co., Ltd.
    China Resources Zizhu Pharmaceutical Co., Ltd.
    Harbin Guokang Pharmaceutical Co., Ltd.
    Youhua Pharmaceutical (Leshan) Co., Ltd.
    Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
    Tianfang Pharmaceutical Co., Ltd.
    Chifeng Mengxin Pharmaceutical Co., Ltd.
    Guangzhou Yuehua Pharmaceutical Co., Ltd.
    Jilin Daojun Pharmaceutical Co., Ltd.
    Guangzhou Xiangxue Pharmaceutical Co., Ltd.
    Henan Runhong Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Xanthinol Nicotinate Tablets market?
What factors are driving Xanthinol Nicotinate Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Xanthinol Nicotinate Tablets market opportunities vary by end market size?
How does Xanthinol Nicotinate Tablets break out by Type, by Application?